Genpharmasec Closes Trading Window for Insiders

Genpharmasec Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut for Promoters, Directors, Key Managerial Persons, Designated Persons, and their immediate relatives. It will remain closed from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. The exact date of the board meeting to consider these results will be communicated later.